F-star Therapeutics, Inc.·4

Mar 11, 4:16 PM ET

Forster Eliot 4

4 · F-star Therapeutics, Inc. · Filed Mar 11, 2021

Insider Transaction Report

Form 4
Period: 2021-03-09
Forster Eliot
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (right to buy)

    2021-03-09+127,924388,901 total
    Exercise: $7.24Exp: 2031-03-09Common Stock (127,924 underlying)
Footnotes (2)
  • [F1]These options were granted under the Issuer's 2015 Equity Incentive Plan.
  • [F2]Twenty five percent (25%) of the total number of shares under the award shall vest on the first anniversary of the Vesting Commencement Date, March 9, 2021, and thereafter in equal monthly installments over the remaining three years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION